HECCD commends @MikeKellyPA, @RepRaulRuizMD, @RepMMM, and @RepGwenMoore on the reintroduction of the Treat and Reduce Obesity Act in the House. We hope the House and Senate will work together to ensure that this critical bill becomes law, ensuring that older people across the.

Our partner @LULAC got it right in their letter to Gov. Newsom - cutting GLP-1 coverage from Medi-Cal is medically unsound and will disproportionately harm communities of color. Check out their letter to learn why protecting Medi-Cal coverage will advance health equity, reduce

What do you want to know?.

Cutting coverage of GLP-1s from Medi-Cal puts black and brown Californians at risk!. Check out this op-ed by @yourcbhn ED, Rhonda Smith, which explores just how detrimental rolling back coverage can be for vulnerable communities.

HECCD applauds the reintroduction of the Treat and Reduce Obesity Act in the U.S. Senate. This legislation is critical for removing barriers to obesity care, especially for communities of color who are disproportionately impacted by this public health crisis. Read HECCD's full.

We are incredibly disappointed by Gov. Newsom's decision to discontinue coverage of AOMs under Medi-Cal. While cutting access to care may save a few dollars in the short run, in the long run, it will cause health care costs to skyrocket as obesity rates increase. Further, it puts.

Check out this Brookings report on the prevalence of uninspected Chinese substances in compounded AOMs. It underscores just how important universal access to AOMs is for ensuring patients can access the highest-quality care.

In light of the CMS announcement, we remain committed to continuing to work with the Trump administration and Congress to help millions of Americans living with obesity access the treatment they deserve. Read our full statement:

Medicare policies are lagging behind science—and it’s costing lives, especially older Americans. It’s time for CMS to expand coverage. Read more about the new rule that could reshape Americans’ access to obesity care.

The push to expand Medicare/Medicaid coverage for FDA-approved AOMs is growing. Nearly 20K health experts, lawmakers, and community members are calling on CMS to expand coverage. Millions need access—let’s close the gap.

Doctors are sounding the alarm and urging CMS to expand Medicare and Medicaid to cover AOMs and save lives. Read Dr. Monalisa Tailor’s new op-ed as she explains how expanding coverage for anti-obesity medication could improve public health and ensure equitable options for all.

Investing in obesity treatment today means lower healthcare costs tomorrow. In his op-ed for Topeka Capital-Journal, Representative Tim Johnson advocates for expanding Medicare/Medicaid coverage for anti-obesity medications—this could save between $ 175 billion and $245 billion.

For millions of Americans suffering from obesity, the threat of developing serious health conditions needs to be addressed. That’s why making anti-obesity medications available to more Americans can save lives. Learn more:

“Obesity is the second leading cause of death in the U.S., responsible for an estimated 500,000 deaths annually.”. Doctors everywhere are sounding the alarm: we need Congress to expand Medicare and Medicaid coverage of anti-obesity medicine and save lives. Read Dr. Chris Ford’s.

Obesity is a chronic disease—full stop. Refusing to recognize it as such means denying millions of Americans the care they deserve. It’s time to demand policies that treat obesity like the complex disease it is.

Black Americans are impacted by obesity at alarming rates. Nearly half of all Black Americans live obesity. This isn’t about willpower—it’s about access to care. Congress must act now to expand Medicare & Medicaid to cover life-saving obesity treatments.

Nearly 20k advocates and countless prominent health care advocacy groups from all 50 states, DC, and Puerto Rico agree: CMS must expand coverage to include anti-obesity medication and save lives. Learn more:

Our coalition of nearly 20,000 health care advocates and 12 major health care groups have called on CMS to expand coverage to include anti-obesity medication. @Newsweek recently shared why this change could be so impactful for millions of people’s health:

It’s estimated that by 2030, almost half of Americans will struggle with obesity. That’s why a coalition of nearly 20,000 advocates and prominent health care advocacy groups are urging CMS today to expand coverage for anti-obesity medications and save lives. Learn more:

1 in 3 Americans living with obesity lack access to affordable treatment options. Congress can connect more people to treatment by expanding Medicare to include anti-obesity medications. Learn more:

We need your voice! CMS proposed expanding Medicare and Medicaid to cover anti-obesity medications—a huge step for millions of Americans living with obesity. But they need to hear from you. Make your voice count. Sign the petition now.